NO122650B - - Google Patents

Download PDF

Info

Publication number
NO122650B
NO122650B NO164999A NO16499966A NO122650B NO 122650 B NO122650 B NO 122650B NO 164999 A NO164999 A NO 164999A NO 16499966 A NO16499966 A NO 16499966A NO 122650 B NO122650 B NO 122650B
Authority
NO
Norway
Prior art keywords
ether
acid
salt
amino
solution
Prior art date
Application number
NO164999A
Other languages
Norwegian (no)
Inventor
R Mizzoni
Stevens G De
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NO122650B publication Critical patent/NO122650B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

Fremgangsmåte til fremstilling av terapeutisk aktive, Process for the production of therapeutically active,

kvaternære forbindelser.quaternary compounds.

Oppfinnelsen vedrører fremstilling av terapeutisk virksomme forbindelser med formel The invention relates to the production of therapeutically active compounds with formula

hvori n betyr et helt tall fra 2 til 5, m betyr et helt tall fra 1 til 4 og p betyr et helt tall fra 0 til 2, Y betyr en direkte binding eller en metylen, 1,1-etylen- eller'1,2-etylengruppe, og wherein n means an integer from 2 to 5, m means an integer from 1 to 4 and p means an integer from 0 to 2, Y means a direct bond or a methylene, 1,1-ethylene- or'1, 2-ethylene group, and

X<®>betyr et syreanion, samt syreaddisjonssalter herav.X<®>means an acid anion, as well as acid addition salts thereof.

i Forbindelsene ifølge oppfinnelsen er f.eks. anvendbarei The compounds according to the invention are e.g. applicable

i form av dyrefdringsmidler som egner seg til oppdrett av fjærkre, spesielt for å nedsette utbyttetap som er å tilbakeføre på den som coccidiose kjente fjærkresykdom. in the form of animal repellants that are suitable for raising poultry, especially to reduce yield losses that can be attributed to the poultry disease known as coccidiosis.

! Coccidiose er en protozo-infeksjon i fordøyelseskanalen, spesielt i unge fjærkre, som unge høner, og kan føre til sterke forstyrrelser i fjærkreoppdrett og store økonomiske tap. Sykdommen forårsakes av coccidiose-frembringere som f.eks. Eimeria Tenella, Eimeria acervulina, Eimerie adenoides, Eimeria agridis, Eimeria brunetti, Eimeria hagani, Eimeria maxima eller Eimeria necatrix, idet infeksjonen tar et mer akutt forløp med visse organismer, som Eimeria tenella, med andre et mer kronisk forløp som Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima eller Eimeria necatrix. ! Coccidiosis is a protozoan infection of the digestive tract, especially in young poultry, such as young hens, and can cause severe disruptions in poultry farming and large economic losses. The disease is caused by coccidiosis agents such as e.g. Eimeria Tenella, Eimeria acervulina, Eimeria adenoides, Eimeria agridis, Eimeria brunetti, Eimeria hagani, Eimeria maxima or Eimeria necatrix, as the infection takes a more acute course with certain organisms, such as Eimeria tenella, with others a more chronic course such as Eimeria acervulina, Eimeria brunetti, Eimeria hagani, Eimeria maxima or Eimeria necatrix.

Anionet X<®>såvel som de nevnte syreaddisjonssalter lar seg fortrinnsvis avlede fra terapeutisk anvendbare uorganiske eller organiske syrer, f.eks. fra halogenhydrogensyrer, som klorhydrogen-eller bromhydrogensyrer, svovel-, fosfor-, salpeter- eller perklor-syrer, såvel som alifatiske, alicykliske, aromatiske eller heterocykliske karbon- eller sulfonsyrer, som maursyre-, eddiksyre-, propionsyre, ravsyre, glykolsyre, melkesyre, eplesyre-, vinsyre-, sitronsyre-, ascorbinsyre, maleinsyre, hydroksymaleinsyre, pyrodruesyre, fenyleddiksyre, benzosyre, p-aminobenzosyre, antranil-syre, p-hyd'roksybenzosyre, salicylsyre, p-aminosalicylsyre, embon-syre, metansulfonsyre, etansulfonsyre, hydroksyetansulfonsyre, etylensulfonsyre, halogenbenzolsulfonsyre, toluolsulfonsyre, naftalinsulfonsyre eller sulfanilsyre, metionin, tryptofan, lysin eller aginin. The anion X<®> as well as the aforementioned acid addition salts can preferably be derived from therapeutically usable inorganic or organic acids, e.g. from hydrohalic acids, such as hydrochloric or hydrobromic acids, sulphurous, phosphoric, nitric or perchloric acids, as well as aliphatic, alicyclic, aromatic or heterocyclic carbonic or sulphonic acids, such as formic, acetic, propionic, succinic, glycolic, lactic , malic acid, tartaric acid, citric acid, ascorbic acid, maleic acid, hydroxymaleic acid, pyruvic acid, phenylacetic acid, benzoic acid, p-aminobenzoic acid, anthranilic acid, p-hydroxybenzoic acid, salicylic acid, p-aminosalicylic acid, embonic acid, methanesulfonic acid, ethanesulfonic acid, hydroxyethanesulfonic acid, ethylenesulfonic acid, halobenzenesulfonic acid, toluenesulfonic acid, naphthalenesulfonic acid or sulfanilic acid, methionine, tryptophan, lysine or aginine.

, Det skal spesielt fremheves 4-amino-2-cyklopropylmetyl-5-(2,4-dimetyl-pyridinium)-metyl-pyrimidinklorid og 4-amino-2-cyklopropylmetyl-5-(2-metylpyridinium)-metyl-pyrimidin-klorid og syreaddisjonssaltene, spesielt hydrokloridene herav. , 4-amino-2-cyclopropylmethyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidine chloride and 4-amino-2-cyclopropylmethyl-5-(2-methylpyridinium)-methyl-pyrimidine chloride should be highlighted and the acid addition salts, especially the hydrochlorides thereof.

De nye forbindelser fremstilles ifølge oppfinnelsen idet man enten The new compounds are produced according to the invention by either

a) omsetter en reaksjonsdyktig ester eller eter av en forbindelse med formel a) reacts a reactive ester or ether of a compound of formula

hvori R betyr en hydroksygruppe, en merkaptogruppe, eller et salt herav med en forbindelse med formel wherein R means a hydroxy group, a mercapto group, or a salt thereof with a compound of formula

eller et salt herav, eller or a salt thereof, or

b) omdanner en til forbindelsen med formel I tilsvarende kvaternær base eller pseudibase i det kvaternære salt og hvis ønsket, omdanner b) converts one to the compound of formula I corresponding quaternary base or pseudobase in the quaternary salt and, if desired, converts

en dannet fri forbindelse i dens syreaddisjonssalt eller et dannet syreaddisjonssalt i den fri forbindelse eller i et annet salt og/eller et resulterende kvaternært salt i et annet kvaternært salt. a formed free compound in its acid addition salt or a formed acid addition salt in the free compound or in another salt and/or a resulting quaternary salt in another quaternary salt.

En reaksjonsdyktig ester av den nevnte 5-R0-metyl-utgangsmateriale er f.eks. esteren av en sterkt uorganisk eller organisk syre, som en halogenhydrogen-, svovel-, sulfon- eller karbaminsyre, f.eks. klorhydrogen-, bromhydrogen-, svovel- eller lavere-alkylsvovelsyre, en lavere alkan- eller benzosulfonsyre, som metan-, etan-, benzol- eller p-toluolsulfonsyre, eller en usubstituert eller N-substituert karbaminsyre, som N,N-dimetylkarbamin- eller N-fenyl-karbaminsyre. Etere av de nevnte 5-R -metylforbindelser er fortrinnsvis lavere alkyl- eller fenyllaverealkyletere, som metyl-, etyl-, isopropyl- eller benzyleter. Fortrinnsvis omsetter reaksjonsdyktige estere av 4-amino-5-RQ-metyl-2-N-pyrimidin-utgangsmateriale i fri form eller i form av deres syreaddisjonssalter med de frie heterocykliske forbindelser, mens de tilsvarende reaksjonsdyktige etere bringes til reaksjon i fri form med syreaddisjonssaltene av de heterocykliske reaksjonsdeltakere. A reactive ester of the aforementioned 5-R0-methyl starting material is e.g. the ester of a strong inorganic or organic acid, such as a hydrohalic, sulfuric, sulphonic or carbamic acid, e.g. hydrochloric, hydrobromic, sulfuric or lower alkylsulfuric acid, a lower alkane or benzosulfonic acid, such as methane-, ethane-, benzol- or p-toluenesulfonic acid, or an unsubstituted or N-substituted carbamic acid, such as N,N-dimethylcarbamic acid or N-phenyl-carbamic acid. Ethers of the aforementioned 5-R-methyl compounds are preferably lower alkyl or phenyl lower alkyl ethers, such as methyl, ethyl, isopropyl or benzyl ether. Preferably, reactive esters of 4-amino-5-RQ-methyl-2-N-pyrimidine starting material react in free form or in the form of their acid addition salts with the free heterocyclic compounds, while the corresponding reactive ethers react in free form with the acid addition salts of the heterocyclic reaction participants.

De kvaternære baser eller pseudobaser kan inneholde hydroksygruppen som anion eller som substituenter av den heterocykliske, ammoniumnitrogenleverende ring. De overføres f.eks. ved behandling med en syre eller et surt reagens som en egnet ioneutveksler i de kvaternære salter. The quaternary bases or pseudobases may contain the hydroxy group as anion or as substituents of the heterocyclic, ammonium nitrogen-giving ring. They are transferred e.g. by treatment with an acid or an acidic reagent as a suitable ion exchanger in the quaternary salts.

De nye forbindelser fåes i fri form, som inneholder en fri 4-aminogruppe, eller i form av deres syreaddisjonssalter, alt etter de betingelser hvorunder fremgangsmåten gjennomføres. Av hensyn til det nære forhold mellom de nye forbindelser i fri form og i form av deres salter er det i det foregående og følgende med de frie forbindelser og saltene ment eventuelt også de tilsvarende salter resp. de frie forbindelser. Dannede syreaddisjonssalter kan på i og for seg kjent måte omdannes i de frie forbindelser, f.eks. ved behandling med milde alkaliske midler, som alkalimetallkarbonater eller -hydro-genkarbonater, eller i andre salter, f.eks. ved hjelp av egnede ioneutvekslere. Tilsvarende som de kvate'rnære baser eller pseudobaser kan dannede frie forbindelser ved reaksjon med uorganiske eller organiske syrer spesielt med slike som er egnet til dannelse av terapeutisk anvendbare salter, f.eks. syrer som gir anionet X<®>, omdannes i syreaddisjonssaltet. The new compounds are obtained in free form, which contains a free 4-amino group, or in the form of their acid addition salts, depending on the conditions under which the process is carried out. Due to the close relationship between the new compounds in free form and in the form of their salts, in the foregoing and the following, the free compounds and salts are possibly also meant the corresponding salts or the free connections. Formed acid addition salts can be converted in a manner known per se into the free compounds, e.g. by treatment with mild alkaline agents, such as alkali metal carbonates or hydrogen carbonates, or in other salts, e.g. using suitable ion exchangers. Similar to the quaternary bases or pseudobases, free compounds formed by reaction with inorganic or organic acids, especially with those which are suitable for the formation of therapeutically usable salts, e.g. acids that give the anion X<®> are converted in the acid addition salt.

En kvaternær ammoniumgruppe RQ kan ved omkvaternisering på kjent måte,overføres i den ønskede gruppe R^, fortrinnsvis med et overskudd av den tilsvarende heterocykliske base. A quaternary ammonium group RQ can, by requaternization in a known manner, be transferred into the desired group R^, preferably with an excess of the corresponding heterocyclic base.

De ovennevnte omsetninger kan gjennomføres ved normalt eller forhøyet trykk etter kjente metoder, i nærvær eller fravær av fortynnelsesmidler, spesielt slike som forholder seg inerte overfor reagensene og formålr å oppløse disse, katalysatorer, kondensasjons-midler og/eller inert atmosfære, ved lave temperaturer, værelsetemperatur eller fortrinnsvis ved forhøyede temperaturer. The above-mentioned reactions can be carried out at normal or elevated pressure according to known methods, in the presence or absence of diluents, especially those that are inert towards the reagents and aim to dissolve them, catalysts, condensation agents and/or inert atmosphere, at low temperatures, room temperature or preferably at elevated temperatures.

Man kan gå ut fra en på et eller annet trinn som mellom-produkt dannet forbindelse og gjennomfører de resterende fremgangs-måtetrinn, eller avbryter fremgangsmåten på et eller annet trinn eller hvor man danner utgangsstoffene under reaksjonsbetingelsene eller hvor man anvender reaksjonskomponentene i form av derivater herav, f.eks. deres salter. Eksempelvis dannes den reaksjonsdyktige ester av 5"RQ-metylforbindelsen, f.eks. en sulfonsyreester, fortrinnsvis under reaksjonsbetingelsene, dvs. i nærvær av den heterocykliske forbindelse. One can proceed from a compound formed as an intermediate product at one or other stage and carry out the remaining procedural steps, or interrupt the process at one or another stage or where the starting substances are formed under the reaction conditions or where the reaction components are used in the form of derivatives thereof , e.g. their salts. For example, the reactive ester of the 5"RQ-methyl compound, for example a sulphonic acid ester, is preferably formed under the reaction conditions, i.e. in the presence of the heterocyclic compound.

I!fremgangsmåten anvendes fortrinnsvis slike utgangs-stoffer som fører til de innledningsvis som spesielt verdifulle omtalte forbindelser. In the process, starting materials are preferably used which lead to the compounds mentioned at the outset as particularly valuable.

Utgangsstoffene er kjente, og kan hvis de er nye fremstilles på i og for seg kjent måte. Således lar f.eks. 4-amino-5-hydroksymetyl-2-R-pyrimidin seg fremstille ved omsetning av et R-karbonsyreamidin eller en tilsvarende imidoester med et laverealkoksy-metylen-malodinitril, reduksjon av det dannede 4-amino-5~cyan-2-R- pyrimidin til tilsvarende 5-aminometylforbindelse, f.eks. med katalytisk aktivert hydrogen, og omdannelse av denne til den ønskede 5-hydroksymetylforbindelse, f.eks. ved innvirkning av salpetersyrling. Den dannede alkohol kan reaksjonsdyktig forestres eller foretres The starting materials are known, and if they are new, can be produced in a manner known per se. Thus allows e.g. 4-amino-5-hydroxymethyl-2-R-pyrimidine is prepared by reaction of an R-carboxylic acid amidine or a corresponding imidoester with a lower alkoxy-methylene-malodinitrile, reduction of the formed 4-amino-5~cyan-2-R- pyrimidine to corresponding 5-aminomethyl compound, e.g. with catalytically activated hydrogen, and converting this into the desired 5-hydroxymethyl compound, e.g. under the influence of nitric acid. The alcohol formed can be reactively esterified or etherified

etter kjente metoder, f.eks. ved behandling med tionyl- eller fosfor-halogenid, et svovel- eller sulfonsyrehalogenid, som tionyl-, sulfuryl-, p-toluolsulfonyl- eller p-brom-benzol-sulfonylklorid. En dannet 4-amino-5-halogenmetyl-2-R-pyrimidinforbindelse kan deretter om- according to known methods, e.g. by treatment with thionyl or phosphorus halide, a sulfuric or sulfonic acid halide, such as thionyl, sulfuryl, p-toluenesulfonyl, or p-bromobenzenesulfonyl chloride. A formed 4-amino-5-halomethyl-2-R-pyrimidine compound can then re-

settes med en vannfri alkohol eller merkaptan til den ønskede eter. Sistnevnte kan f.eks. også fremstilles ved reaksjon av et syreaddi-sj onssalt av en R-karbonsyreamidin med et foretret a-alkoksymetyl-8- is added with an anhydrous alcohol or mercaptan to the desired ether. The latter can e.g. is also produced by reaction of an acid addition salt of an R-carboxylic acid amidine with an etherified α-alkoxymethyl-8-

R -propionitril.R -propionitrile.

o o

De kvaternære baser eller pseudobaser kan man få ved reduksjon av de tilsvarende oksoforbindelser, dvs. av cykliske amider, f.eks. ved hjelp av komplekse lettmetallhydrider som litiumaluminiumhydrid eller natriumborhydrid. The quaternary bases or pseudobases can be obtained by reduction of the corresponding oxo compounds, i.e. of cyclic amides, e.g. using complex light metal hydrides such as lithium aluminum hydride or sodium borohydride.

Fremstillingen av de nye forbindelser beskrives nærmereThe production of the new compounds is described in more detail

i de følgende eksempler. Temperaturene er angitt i Celsiusgrader.in the following examples. The temperatures are indicated in degrees Celsius.

De anvendte ioneutvekslere er beskrevet i Ullmann, Encyklopådia der technischen Chemie, bind 8' (1957), den med Amberlite IRA 400 be-tegnede harpiks er en sterkt basisk ioneutveksler på basis av kvaternære ammoniumioner slik den f.eks. er beskrevet i US-patent nr. 2.591.573. The ion exchangers used are described in Ullmann, Encyklopådia der technischen Chemie, volume 8' (1957), the resin designated Amberlite IRA 400 is a strongly basic ion exchanger based on quaternary ammonium ions as it e.g. is described in US patent no. 2,591,573.

Eksempel 1.Example 1.

En oppløsning av 20,2 g 4-amino-2-cyklopentyl-5-hydroksymetyl-pyrimidih-hydroklorid i vann gjøres basisk med en mettet vandig kaliumkarbonatoppløsning og det organiske materiale ekstraheres med n-butanol. Det organiske ekstrakt inndampes til tørrhet og de dannede 9,7 g 4-amino-2-cyklopentyl-5-hydroksymetyl-pyrimidin, med smp. 101-104°C, oppløses i 50 ml 2,4-lutidin. Oppløsningen blandes ved værelsetemperatur porsjonsvis med 9,73 g pulverformet o-toluolsulfonylklorid, hensettes noen dager ved -15°C og deretter 5 dager ved værelsetemperatur, idet produktet faller'ut. Det filtreres fra og vaskes med isopropanol og omkrystalliseres deretter av en blanding av metanol og isopropanol, idet 4-amino-2-cyklopentyl-5-(2,4-dimetyl-pyridinium)-metyl-pyrimidin-klorid-hydroklorid med formel krystalliserer ved konsentrering for å fjerne metanolen, smp. 254-255°C. A solution of 20.2 g of 4-amino-2-cyclopentyl-5-hydroxymethyl-pyrimidine hydrochloride in water is made basic with a saturated aqueous potassium carbonate solution and the organic material is extracted with n-butanol. The organic extract is evaporated to dryness and the formed 9.7 g of 4-amino-2-cyclopentyl-5-hydroxymethyl-pyrimidine, with m.p. 101-104°C, dissolve in 50 ml of 2,4-lutidine. The solution is mixed at room temperature in portions with 9.73 g of powdered o-toluenesulfonyl chloride, left for a few days at -15°C and then 5 days at room temperature, the product falling out. It is filtered off and washed with isopropanol and then recrystallized from a mixture of methanol and isopropanol, 4-amino-2-cyclopentyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidine-chloride-hydrochloride with the formula crystallising at concentration to remove the methanol, m.p. 254-255°C.

Utgangsmaterialet kan f.eks. fåes på følgende måte:The starting material can e.g. obtained in the following way:

En suspensjon av 55 g natriumcyanid i 265 ml dimetyl-sulfoksyd blandes ved 110-115°C med 105 g cyklopentylklorid, reaksj onsblandingen holdes i 3 timer ved 125°C, avkjøles deretter og fortynnes med 1000 ml vann, ekstraheres deretter 4 ganger med metylenklorid. Den organiske oppløsning ekstraheres deretter kaldt med 6-n saltsyre, vaskes deretter med vann og tørkes over vannfri magnesiumsulfat, filtreres og inndampes. Cyklopentylcyanidet destilleres 2 ganger og utvinnes ved 63°C ved 15 mm Hg. A suspension of 55 g of sodium cyanide in 265 ml of dimethyl sulfoxide is mixed at 110-115°C with 105 g of cyclopentyl chloride, the reaction mixture is kept for 3 hours at 125°C, then cooled and diluted with 1000 ml of water, then extracted 4 times with methylene chloride . The organic solution is then extracted cold with 6-n hydrochloric acid, then washed with water and dried over anhydrous magnesium sulfate, filtered and evaporated. The cyclopentyl cyanide is distilled twice and recovered at 63°C at 15 mm Hg.

En oppløsning av 18 g cyklopentylcyanid i 9,2 g etanol behandles ved ,-20°C med 16,2 g vannfritt bromhydrogen og hensettes i 16 timer ved -15°C. Den krystallinske utfelling suges fra, vaskes med en liten mengde.eter og tørker i vakuum, det dannede cyklopenta-karboksimino-etyleter-hydrobromid smelter ved 80-82°C. A solution of 18 g of cyclopentyl cyanide in 9.2 g of ethanol is treated at -20°C with 16.2 g of anhydrous hydrogen bromide and allowed to stand for 16 hours at -15°C. The crystalline precipitate is suctioned off, washed with a small amount of ether and dried in vacuo, the cyclopenta-carboxyimino-ethyl ether hydrobromide formed melts at 80-82°C.

Til en oppløsning av 153, 6 g cyklopentankarboksimino-etyleter-hydrobromid i 120 ml etanol blandes med en mettet etanolisk ammoniakkoppløsning, idet det ved tilsetningens avslutning i reak-*BthQJ3|iblandingen er tilstede et overskudd på ammoniakk. Reaksj ons-blandingen omrøres i 18 timer ved værelsetemperatur, konsentreres deretter under nedsatt trykk og avkjøles. Det dannede krystallinske guanidocyklopentan-hydrobromid smelter ved l48°C. ;En'oppløsning-av 12,3 g natrium i 500 ml vannfri etanol blandes ved 0 til -5°C i løpet av en halv time med en oppløsning av 103>5g guanido-cyklopentan-hydrobromid i 250 ml vannfri etanol. Reaksjonsblandingen omrøres i et kvarter og filtreres for å fjerne dannet natriumbromid. Filtratet settes deretter i løpet av li time ved 0 til -5°C til en oppløsning av 6554 g etoksymetylen-malodinitril i 685 ml vannfri etanol og den dannede blanding omrøres i 3 timer ved denne temperatur og filtreres deretter. Filterresiduet vaskes med en liten mengde etanol, det vakuumtørkede 4-amino-5_cyano-2-cyklopentyl-pyrimidin smelter etter omkrystallisering fra isopropanol ved l6l-l62°C. ;En blanding av 18,8 g 4-amino-5-cyano-2-cyklopentyl-pyrimidin og 2 g av en 10#-ig palladium-på-kull-katålysator i 250 ;ml 3-n saltsyre hydreres ved ca. 3å atmosfæres initialtrykk til opptak av 2 molekvivalenter hydrogen. Under reduksjonen danner det seg den Schiffske base, som hydrolyseres til aldehydet og dette reduseres videre til hydroksymetylforbindelsen. Katalysatoren filtreres fra og filtratet inndampes til tørrhet. Spor av vann fjernes azeotropisk med isopropanol, idet det utfelte ammoniumklorid frafiltreres kon-tinuerlig. Residuet omkrystalliseres to ganger fra isopropanol og man får således 4-amino-2-cyklopentyl-5_hydroksymétyl-pyrimidin-hydroklorid, som smelter ved 110-111°C. Forbindelsens struktur er korrekt på grunn av elementæranalyse og kjerneresonansspektrum. ;Eksempel 2.;En oppløsning av 35 g 4-amino-2-cyklobutylmetyl-5-hydroksymetyl-pyrimidin i 250 ml nydestillert 2,4-lutidin blandes porsjonsvis under omrøring og ved værelsetemperatur med 34,7 g pulverformet p-toluolsulfonylklorid. Reaksjonsblandingen avkjøles i 48 timer ved -15°C, hensettes deretter ved værelsetemperatur i 4 dager og det faste materiale filtreres fra og vaskes med aceton. 4-amino-2-cyklobutylmetyl-5-(2,4-dimetyl-pyridinium)-metyl-pyrimidinklorid-hydroklorid med formel ; ; smelter etter omkrystallisering fra vannfri etanol ved 240-242°C. ;Utgangsmaterialet fåes på følgende måte:;En blanding av 23,6 g litiumaluminiumhydrid i 500 ml eter blandes under omrøring med en oppløsning av 50 g cyklobutan-karbonsyre i 500 ml eter, idet man ved tilsetningen lar det koke lett under tilbakeløp. Blandingen kokes under tilbakeløp i ytterligere 3 timer, avkjøles deretter i et isbad og blandes med 71,6 ml av en 15%- ig vandig natronlutoppløsning, idet man arbeider i en nitrogenatmosfære. Den uorganiske utfelling filtreres fra og vaskes med eter, filtratet og etervaskevæsken forenes og inndampes. Residuet destilleres og cyklobutylmetanol oppfanges ved l42-l43°C. 36,2 g av produktet oppløses i 250 ml vannfri eter og avkjøles til -70°C, behandles deretter med 14,8 ml fosfortribromid i 20 ml eter, temperaturen bibeholdes under omrøring i 2 timer ved -65 til~70°C og bringes deretter langsomt til værelsetemperatur. Etter fortynning med 10 ml vann rystes blandingen og den adskilte eteroppløsriing ekstraheres to ganger med en mettet vandig natrium-karbonatoppløsning. Vaskevæsken ettervaskes med eter. De forenede eterekstrakter tørkes over magnesiumsulfat og inndampes, residuet destilleres og det ønskede cyklobutylmetylbromid oppfanges ved 134-136°C. .En suspensjon av 10,5 g natriumcyanid i 76,4 ml dimetyl-sulfoksyd oppvarmes til 50°C og blandes deretter dråpevis i løpet av 10 min. under omrøring med 28,5 g cyklobutylmetylbromid, den dannede blanding oppvarmes i 2 timer ved 70°C, avkjøles deretter til værelsetemperatur og fortynnes med 150 ml vann. Det ekstraheres 5 ganger med eter, eterekstraktet ekstraheres 2 ganger med kald 6-n saltsyre og 2 ganger med vann, tørkes deretter over magnesiumsulfat og inndampes. Residuet destilleres og cyklobutylacetonitrilet oppfanges ved 78°C og 38 mm Hg. ;En oppløsning av 11,6 g cyklobutylacetonitril i 5>6 g etanol behandles ved -30°C til -40°C med 9, 9 g vannfri bromhydrogen-syre og reaksjonsblandingen hensettes i 16 timer, ved -15°C. Det krystallinske produkt filtreres fra og tørkes under nedsatt trykk over fosforpentoksyd, det ønskede cyklobutyl-acetimino-etylester-hydrobromid smelter ved 79-8l°C ;En oppløsning av det således dannede produkt i 10 ml vannfri etanol behandles med et lett overskudd av en mettet etanolisk ammoniakkoppløsning. Reaksjonsblandingen omrøres i 16 timer ved værelsetemperatur og konsentreres deretter til et lite volum. Det dannede krystallinske produkt filtreres fra, vaskes med eter og tørkes i vakuum, det således dannede cyklobutyl-acetamidin-hydrobromid smelter ved 152-156°C. ;En oppløsning av 2,3 g natrium i 100 ml vannfri etanol blandes, ved 0°C i løpet av en i time med en oppløsning av 18,4 g cyklobutyl-acetamidin-hydrobromid i 100 ml vannfri etanol. Blandingen omrøres kaldt i 15 min. og det dannede natriumbromid filtreres fra. Filtratet settes deretter i løpet av en \ time ved'0°C til -15°C til 12 g etoksymetylen-maodinitril i 110 ml etanol og reaksjonsblandingen omrøres i 4 timer ved 0°C. Det dannede faste produkt filtreres fra, vaskes med en liten mengde kald vannfri etanol og tørkes i vakuum, det ønskede 4-amino-5-cyano-2-cyklobutylmetyl-pyrimidin smelter ved 179-l8l°C. ;En blanding av 18,8 g 4-amino-5-cyano-2-cyklobutylmetyl-pyrimidin og omtrent 5 g Raney-nikkel i 250 ml metanol og 50 ml flytende ammoniakk hydreres ved ca. 3 atmosfærers initialtrykk til teoretisk opptak av hydrogen. Katalysatoren frafiltreres, filtratet inndampes og det oljeaktige residuum oppløses i vannfri etanol og overføres ved tilsetning av en etanolisk klorhydrogensyreoppløsning til positiv Kongorød-reaksjon i hydrokloridet. Den dannede utfelling filtreres fra og vaskes med vannfri etanol, 4-amino-5-aminometyl-2-cyklobutylmetyl-pyrimidin-dihydroklorid smelter ved 259-262°C. ;En oppløsning av 24,3 g natriumnitrit i 1000 ml vann settes til 82,5 g 4-amino-5_aminometyl-2-cyklobutylmetyl-pyrimidin-dihydroklorid i 1100 ml vann, tilsetningen utføres i løpet av 2 timer ved 50-55°C. Den dannede reaksjonsblanding omrøres i 6 timer ved denne temperatur, filtreres deretter,'konsentreres under nedsatt trykk og gjøres basisk kaldt med en mettet vandig natriumkarbonat-oppløsning. Den faste utfelling filtreres fra, vaskes med en liten mengde kaldt vann og rørkes. 4-amino-2-cyklobutylmetyl-5-hydroksymetyl-pyrimidin smelter etter omkrystallisering fra eddiksyreetyl-ester ved 137°C. ;Eksempel 3.;9,2 g 4-amino-2-cyklobutylmetyl-5-hydroksymetylpyrimidin oppløses i 75 ml 2-picolin og blandes ved værelsetemperatur under omrøring med 9,1 g p-toluolsulfonylklorid, reaksjonsblandingen holdes i 2 dager ved -15°C og 4 dager ved værelsetemperatur. Reaksj onsblandingen filtreres og residuet vaskes med aceton. Etter omkrystallisering fra vannfri etanol smelter det dannede 4-amino-2-cyklobutylmetyl-5-(2-metyl-pyridinium)-metyl-pyrimidin-klorid-hydroklorid med formel ; ; Eksempel 4.j<1>;jjEn oppløsning av 2,2 g 4-amino-2-cyklopentyl-5-hydroksymetyl-pyrimidin i 12 ml omdestillert 2-picolin blandes under omrøring med 2,15 g p-toluolsulfonylklorid. Reaksjonsblandingen hensettes i 36j'timer ved værelsetemperatur og fortynnes deretter med eter, idet det danner seg et gummilignende bunnfall som krystalliserer ved rivning]. Det overskytende 2-picolin fjernes ved avdekantering av overståendej ;væske, utfellingen oppløses i isopropanol og utfelles med eter. Utfellingen gjentas ytterligere 3 ganger. Det faste materiale oppløses til slutt i 100 ml 0,06-n saltsyre og oppløsningen helles gjennom en i kloridform befinnende ioneutveksler harpiks (Amberlite ÆRA 400). Eluatet inndampes på dampbad og man får således 4-amino-2-cyklopentyl-5-(2-metyl-pyridinium)-metylpyrimidin-klorid-hydroklorid! ,med formel ; ; Eksempel 5. 1,;j;En oppløsning av 18,5 g 4-amino-2-cyklopropyl-metyl-5-hydroksy-metyl-pyrimidin i 100 ml 2-picolin blandes med 19,9 g p-toluolsulfonylklorid. Reaksjonsblandingen hensettes i 4 dager ved værelsetemperatur og fortynnes deretter med eter, idet det dannes en utfelling. Den ovenstående oppløsning dekanteres fra, residuet oppløses i jisopropanol og produktet utfelles med eter, utfellingen gjentas 4 ganger, inntil man ikke mer kan fastslå 2-picolin. Det faste materiale oppløses i 100 ml vann og oppløsningen helles gjennom en jkolonne inneholdende en ioneutveksler (Amberlite IRA ;400) i kloridform. Det vandige filtrat fordampes under nedsatt trykk oog g mraen sidfuår et 'såomlkedryess ta4l-almisineroe-2s -fcrya kloepn rboplaynld-minetg yalv -5m-e(t2a-nmoetl yolg -pyirsoipdrinopiuamno-l, ;metyl)-pyrimidin-klorid-hydroklorid med formel; ; som smelter ved 225,5 - 226,5°C.;Utgangsmaterialet fremstilles på følgende måte:;Til en suspensjon av 4l,l g litiumaluminiumhydrid i;300 ml vannfri eter settes under omrøring en oppløsning av 100 g cyklopropankarbonsyre i 300 ml eter således at oppløsningsmidlet kokes svakt, videreomrøres i 8 timer og kokes under tilbakeløp. Reaksjonsblandingen fortynnes deretter med 500 ml eter, og 130 ml ;av en 15$-ig vandig natronlutoppløsning innrøres under isavkjøling, blandingen filtreres og residuet vaskes med eter, filtratet tørkes og inndampes. Residuet destilleres og cyklopropylmetanol utvinnes ved 122-126°c'. n^<5>s .1,4299. ;En oppløsning av 89,1 g cyklopropylmetanol oppløses i 350 ml vannfri eter, oppløsningen avkjøles til -70°C og 40,8 g fosfortribromid tilsettes dråpevis under omrøring i løpet av \ time. ;I løpet av 16 timer lar man blandingens temperatur øke til værelsetemperatur og -blander deretter med 12 ml vann, og det organiske sjikt adskilles, vaskes med mettet vandig natriumkarbonatoppløsning og vann, tørkes og inndampes. Residuet destilleres og cyklopropylmetyl-bromidet utvinnes ved 102-110°C n^5 = 1,4752. ;En suspensjon av 51,9 g natriumcyanid i 377 ml dimetyl-sulfoksyd blandes med 126,5 g cyklopropylmetylbromid, idet temperaturen holdes mellom 55_60°C. Derpå øker man temperaturen til 70°C i to timer, avkjøler blandingen, fortynner den méd 500 ml vann og ekstraherer den med eter. Ekstraktet vaskes med vann<p>g 25 ml n-saltsyre, tørkes og inndampes og residuet destilleres, cyklopropyl-acetonitrilet utvinnes ved l42-l47°C, n^<5>= 1,4218. ;I en oppløsning av 101 g cyklopropylacetonitril i 6l,4 g vannfri etanol innføres klorhydrogengass så lenge inntil det er opp-tatt 48,3 g herav. Etter blandingens henstand natten over avfiltreres ved -20°C den dannede utfelling, vaskes med vann og tørkes under nedsatt trykk. Man får således det hygroskopiske cyklopropyl-acetimino-etyleter-hydroklorid. ;Til oppløsningen av 173,1 g cyklopropyl-acetiminoetyl-eter-hydroklorid i 100 ml vannfri etanol settes hurtig under om- røring og avkjøling 130 ml 6,3_n etanolisk ammoniakk. Reaksjonsblandingen hensetter man i 16 timer ved værelsetemperatur, filtrerer og konsentrerer filtratet til det halve volum, hvorpå etter iskjøling og gnidning det dannes krystallisasjon. Det dannede cyklopropyl-acetamidin-hydroklorid avfiltreres, vaskes med vannfri eter og tørkes under nedsatt trykk. ;Oppløsningen av 136,6 g cyklopropyl-acetamidin-hydroklorid i 700 ml vannfri etanol blir i løpet av \ time under omrøring ved 15°C satt til den av 23,6 g natrium og 950 ml vannfri etanol dannede oppløsning. Etter tilsetning av filtreringscellulose filtreres blandingen gjennom en glassinternutsch og filtratet settes til oppløs-ningen av 130:g etoksymetylenmalodinitril i 130 ml vannfri etanol i løpet av 1/4 time ved -5 til -10°C. Blandingen omrører man i 3 timer ved denne temperatur, filtrerer og vasker residuet med kald vannfri etanol og tørker i vakuum ved 50°C. Man får således 4-amino-5~cyano-2-cyklopropyl-metyl-pyrimidin, smp. l8l-l82,5°C. ;Suspensjonen av 17,4 g 4-amino-5-cyano-2-cyklopropyl-metyl-pyrimidin og 2,5 g av en 10$-ig palladium-på-kull-katalysator i 200' ml iseddik mettes med vannfritt klorhydrogen og hydreres ved et begynnelsestrykk på 10,2 atmosfærer, etter ca. 6 timer er den teore-tiske mengde hydrogen absorbert. Blandingen fortynnes med vann, filtreres og filtratet inndampes under nedsatt trykk. Til residuet settes isopropanol, som igjen avdestilleres for å fjerne vann og eddiksyre. Endeligi oppvarmes residuet på dampbad i en time under nedsatt trykk og omkrystalliseres fra en blanding av isopropanol og metanol, man får således 4-amino-5-aminometyl-2-cyklopropylmetyl-pyrimidin-dihydroklorid med smp. 228,5-229°C. ;Til en oppløsning av 75>8 g 4-amino-5-aminometyl-2-cyklo-propylmetyl-pyrimidin-dihydroklorid i 1000 ml vann dryppes ved 55°C ;i løpet av 2 1/4 time under omrøring oppløsningen av 23 g natriumnitrit i 100 ml vann, blandingen holder man deretter i 6 timer ved 54°C og 16 timer ved værelsetemperatur. Deretter behandles det med trekull etter tilsetning av filtreringscellulose, filtreres og filtratet konsentreres under nedsatt trykk til et volum på 500 ml. Kon-sentratet avkjøles til 5°, nøytraliseres med mettet natriumkarbonat-oppløsning til pH 7,5 - 8,0 og ekstraheres med n-butanol, ekstraktet tørkes og konsentreres under nedsatt trykk til begynnende krystallisasjon. Etter tilsetning av eter filtreres blandingen, residuet vaskes med eter, man får således 4-amino-2-cyklopropylmetyl-5_hydroksymetyl-pyrimidin, smp. l43-l46°C. ;Overføringen av 4-amino-5-aminometyl-2-cyklopropyl-metyl-pyrimidin-dihydroklorid i 4-amino-2-cyklopropylmetyl-5-hydroksymetyl-pyrimidin kan også foretas på følgende måte: Til en oppløsning av 26,6 g 4-amino-5-aminometyl-2-cyklo-propylmetyl-pyrimidin-dihydroklorid i 400 ml vann settes oppløsningen av 7,5 g natriumnitrit i 400 ml vann i løpet av 3 timer, idet temperaturen holdes ved 50-55°C. Den homogene oppløsning omrøres i 17 timer ved denne temperatur, i løpet av hvilken tid pH etterhvert innstilles til ca. 7,5-8 med mettet natriumkarbonatoppløsning. Blandingen inndampes til tørrhet og det gule residuum ekstraheres med 4 porsjoner kokende 90$-ig vandig aceton. Den organiske oppløsning inndampes til lite volum og det gjenværende vann fjernes azeotropisk med etanol. Blandingen filtreres, filtratet surgjøres med etanolisk saltsyre til pH ca. 4 og fortynnes med eter. Etter kort henstand frafiltreres det utfelte gule bunnfall, rives i en morter med eter, frafiltreres og tørkes i vakuum ved 50°C Det dannede 4-amino-2-cyklopropylmetyl-5-hydroksymetyl-pyrimidin-hydroklorid oppløses i den for oppløsning nødvendige minimale vannmengde og oppløsningen tilsettes fast kaliumkarbonat under avkjøling og omrøring så lenge til det utskiller seg et oljeaktig sjikt. Deretter ekstraheres det så lenge med n-butanol til sistnevnte ekstrakt er fargeløst. De forenede ekstrakter tørkes over kaliumkarbonat, filtreres og inndampes under nedsatt trykk. Residuet utdrives med eter, frafiltreres, vaskes med eter og tørkes ;i vakuum ved 50°C. Man får således 4-amino-2-cyklopropylmetyl-5_ hydroksymetyl-pyrimidin. ;Eksempel 6.;En oppløsning av 2,2 g 4-amino-2-cyklopropylmetyl-5-hydroksymetyl-pyrimidin i 15 ml nydestillert 2,4-lutidin blandes med 2,24 g p-toluolsulfonylklorid og blandingen hensettes i 4 dager ved værelsetemperatur. Derpå fortynnes det med eter, hvorpå det utskiller seg en utfelling, hvorfra den overstående oppløsning avdekanteres. Residuet oppløses i isopropanol og produktet utfelles 4 ganger med eter, hvorpå lukten av 2,4-lutidin forsvinner. Det dannede krystallinske produkt oppløses i 100 ml vann og oppløsningen føres gjennom en søyle med en i kloridform foreliggende ioneutvekslerharpiks (Amberlite IRA 400). Det vandige eluat konsentreres under nedsatt trykk og den dannede utfelling omkrystalliseres fra en blanding av metanol og isopror.^1. Man får således 4-amino-2-cyklopropylmetyl-5-(2,4-dimetyl-pyridiniuin)-metyl-pyrimidin-klorid-hydroklorid med ; som smelter ved 250,5 - 251°C under spaltning.;Eksempel 7 .;En oppløsning av 19 g 4-amino-2-cyklopropyl-metyl-5-hydroksymetyl-pyrimidin i 100 ml 2,4-lutidin avkjøles og blandes porsjonsvis med 20,4 g p-toluolsulfonylklorid. Blandingen filtreres og filtratet hensettes i 18 timer ved -20°C og 5\ dag ved værelsetemperatur og; fortynnes deretter med eter. Den gummilignende utfelling utdrives; med eter og omkrystalliseres fra en blanding av isopropanol. og eter. En oppløsning av 40,3 g av det krystallinske materiale i 3,00 ml vann, inneholdende 5 ml 0,006 n saltsyre, behandles med aktivkull, filtreres og filtratet føres gjennom en søyle med en i kloridform befinnende ioneutvekslerharpiks (Amberlite IRA 400). Søylen vaskes'med 500 ml vann, de kombinerte eluater behandles igjen med aktivkull, filtreres og inndampes under nedsatt trykk. Til residuet settes isopropanol som avdestilleres for azeotropisk å fjerne gjenblivende vann. Det således tørkede residuum suspenderes i aceton og suspensjonen filtreres. Residuet vaskes med aceton og omkrystalliseres fra en 1:1 blanding av metanol og isopropanol. Man får således 4-amino-2-cyklopropyl-metyl-5-(2,4-dimetyl-pyridinium)-metyl-pyrimidm-klo1 rid-hydroklorid, smp. 250,5 - 251 oC under spaltnxng, hvilket er identisk med det ifølge eksempel 6 dannede produkt. Eksempel 8. ;En suspensjon av 2,7 g 4-amino-5-klormetyl-2-cyklo-propylmetyl-pyrimidin-hydroklorid i 20 ml 2,4-lutidin oppvarmes i 4 dager på dampbad, avkjøles deretter og fortynnes med eter. Den overstående oppløsning dekanteres av og residuet kokes opp med isopropanol. Etter avkjøling filtreres det og residuet vaskes med isopropanol og omkrystalliseres fra en blanding av metanol og isopropanol. Det dannede 4-amino-2-cyklopropyl-metyl-5-(2,4-dimetyl-pyri-dinium)-metyl-pyrimidin-klorid-hydroklorid smelter ved 252°C under spaltning og er identisk med det ved fremgangsmåten ifølge eksempel 6 og 7 dannede produkt. ;Utgangsmaterialet kan fåes på følgende måte:;En oppløsning av 5,8 g 4-amino-2-cyklopropylmetyl-5-hydroksymetyl-pyrimidin i 10 ml dimetylformamid blandes under om-røring og avkjøling til en temperatur på under 5°C dråpevis med 2,45 ml tionylklorid. Etter to timers omrøring under isbadavkjøling hensettes reaksjonsblandingen i 18 timer ved 0°C, fortynnes deretter med eter og utfellingen frafiltreres. Denne tritueres med eter og aceton og omkrystalliseres fra en blanding av isopropanol og eter, 4-amino-5-klormetyl-2-cyklopropylmetyl-pyrimidin-hydroklorid smelter ved 191-195°C under spaltning. * A solution of 153.6 g of cyclopentanecarboxyimino-ethyl ether hydrobromide in 120 ml of ethanol is mixed with a saturated ethanolic ammonia solution, an excess of ammonia being present in the reaction mixture at the end of the addition. The reaction mixture is stirred for 18 hours at room temperature, then concentrated under reduced pressure and cooled. The crystalline guanidocyclopentane hydrobromide formed melts at 148°C. A solution of 12.3 g of sodium in 500 ml of anhydrous ethanol is mixed at 0 to -5°C during half an hour with a solution of 103>5 g of guanidocyclopentane hydrobromide in 250 ml of anhydrous ethanol. The reaction mixture is stirred for fifteen minutes and filtered to remove sodium bromide formed. The filtrate is then added during one hour at 0 to -5°C to a solution of 6554 g of ethoxymethylene-malodinitrile in 685 ml of anhydrous ethanol and the resulting mixture is stirred for 3 hours at this temperature and then filtered. The filter residue is washed with a small amount of ethanol, the vacuum-dried 4-amino-5-cyano-2-cyclopentyl-pyrimidine melts after recrystallization from isopropanol at 161-162°C. A mixture of 18.8 g of 4-amino-5-cyano-2-cyclopentyl-pyrimidine and 2 g of a 10# palladium-on-charcoal catalyst in 250 ml of 3-n hydrochloric acid is hydrated at approx. 3 atmospheric initial pressure to absorb 2 mole equivalents of hydrogen. During the reduction, Schiff's base is formed, which is hydrolysed to the aldehyde and this is further reduced to the hydroxymethyl compound. The catalyst is filtered off and the filtrate is evaporated to dryness. Traces of water are removed azeotropically with isopropanol, the precipitated ammonium chloride being continuously filtered off. The residue is recrystallized twice from isopropanol and 4-amino-2-cyclopentyl-5-hydroxymethyl-pyrimidine hydrochloride is thus obtained, which melts at 110-111°C. The structure of the compound is correct due to elemental analysis and nuclear resonance spectrum. ;Example 2. ;A solution of 35 g of 4-amino-2-cyclobutylmethyl-5-hydroxymethyl-pyrimidine in 250 ml of freshly distilled 2,4-lutidine is mixed in portions with stirring and at room temperature with 34.7 g of powdered p-toluenesulfonyl chloride. The reaction mixture is cooled for 48 hours at -15°C, then allowed to stand at room temperature for 4 days and the solid material is filtered off and washed with acetone. 4-amino-2-cyclobutylmethyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidine chloride hydrochloride of the formula; ; melts after recrystallization from anhydrous ethanol at 240-242°C. ;The starting material is obtained in the following way:;A mixture of 23.6 g of lithium aluminum hydride in 500 ml of ether is mixed with stirring with a solution of 50 g of cyclobutane-carbonic acid in 500 ml of ether, allowing it to boil slightly under reflux during the addition. The mixture is refluxed for a further 3 hours, then cooled in an ice bath and mixed with 71.6 ml of a 15% aqueous sodium hydroxide solution, working under a nitrogen atmosphere. The inorganic precipitate is filtered off and washed with ether, the filtrate and the ether washing liquid are combined and evaporated. The residue is distilled and cyclobutyl methanol is collected at 142-143°C. 36.2 g of the product is dissolved in 250 ml of anhydrous ether and cooled to -70°C, then treated with 14.8 ml of phosphorus tribromide in 20 ml of ether, the temperature is maintained with stirring for 2 hours at -65 to ~70°C and brought then slowly to room temperature. After dilution with 10 ml of water, the mixture is shaken and the separated ether solution is extracted twice with a saturated aqueous sodium carbonate solution. The washing liquid is then washed with ether. The combined ether extracts are dried over magnesium sulphate and evaporated, the residue is distilled and the desired cyclobutyl methyl bromide is collected at 134-136°C. . A suspension of 10.5 g of sodium cyanide in 76.4 ml of dimethyl sulphoxide is heated to 50°C and then mixed dropwise over 10 minutes. while stirring with 28.5 g of cyclobutyl methyl bromide, the resulting mixture is heated for 2 hours at 70°C, then cooled to room temperature and diluted with 150 ml of water. It is extracted 5 times with ether, the ether extract is extracted 2 times with cold 6-n hydrochloric acid and 2 times with water, then dried over magnesium sulfate and evaporated. The residue is distilled and the cyclobutyl acetonitrile is collected at 78°C and 38 mm Hg. A solution of 11.6 g of cyclobutylacetonitrile in 5>6 g of ethanol is treated at -30°C to -40°C with 9.9 g of anhydrous hydrobromic acid and the reaction mixture is allowed to stand for 16 hours, at -15°C. The crystalline product is filtered off and dried under reduced pressure over phosphorus pentoxide, the desired cyclobutyl-acetimino-ethyl ester hydrobromide melts at 79-81°C; A solution of the product thus formed in 10 ml of anhydrous ethanol is treated with a slight excess of a saturated ethanolic ammonia solution. The reaction mixture is stirred for 16 hours at room temperature and then concentrated to a small volume. The crystalline product formed is filtered off, washed with ether and dried in vacuum, the cyclobutyl acetamidine hydrobromide thus formed melts at 152-156°C. A solution of 2.3 g of sodium in 100 ml of anhydrous ethanol is mixed, at 0°C, over the course of one hour with a solution of 18.4 g of cyclobutyl-acetamidine hydrobromide in 100 ml of anhydrous ethanol. The mixture is stirred cold for 15 min. and the formed sodium bromide is filtered off. The filtrate is then added during one hour at 0°C to -15°C to 12 g of ethoxymethylene-maodinitrile in 110 ml of ethanol and the reaction mixture is stirred for 4 hours at 0°C. The solid product formed is filtered off, washed with a small amount of cold anhydrous ethanol and dried in vacuo, the desired 4-amino-5-cyano-2-cyclobutylmethyl-pyrimidine melting at 179-181°C. ;A mixture of 18.8 g of 4-amino-5-cyano-2-cyclobutylmethyl-pyrimidine and approximately 5 g of Raney nickel in 250 ml of methanol and 50 ml of liquid ammonia is hydrated at approx. 3 atmospheres initial pressure for theoretical uptake of hydrogen. The catalyst is filtered off, the filtrate is evaporated and the oily residue is dissolved in anhydrous ethanol and transferred by adding an ethanolic hydrochloric acid solution to a positive Congo red reaction in the hydrochloride. The precipitate formed is filtered off and washed with anhydrous ethanol, 4-amino-5-aminomethyl-2-cyclobutylmethyl-pyrimidine-dihydrochloride melts at 259-262°C. ;A solution of 24.3 g of sodium nitrite in 1000 ml of water is added to 82.5 g of 4-amino-5_aminomethyl-2-cyclobutylmethyl-pyrimidine-dihydrochloride in 1100 ml of water, the addition is carried out over 2 hours at 50-55°C . The resulting reaction mixture is stirred for 6 hours at this temperature, then filtered, concentrated under reduced pressure and made cold basic with a saturated aqueous sodium carbonate solution. The solid precipitate is filtered off, washed with a small amount of cold water and stirred. 4-amino-2-cyclobutylmethyl-5-hydroxymethyl-pyrimidine melts after recrystallization from acetic acid ethyl ester at 137°C. ;Example 3.;9.2 g of 4-amino-2-cyclobutylmethyl-5-hydroxymethylpyrimidine is dissolved in 75 ml of 2-picoline and mixed at room temperature with stirring with 9.1 g of p-toluenesulfonyl chloride, the reaction mixture is kept for 2 days at -15 °C and 4 days at room temperature. The reaction mixture is filtered and the residue is washed with acetone. After recrystallization from anhydrous ethanol, the formed 4-amino-2-cyclobutylmethyl-5-(2-methyl-pyridinium)-methyl-pyrimidine-chloride-hydrochloride melts with the formula; ; Example 4.j<1>;jjA solution of 2.2 g of 4-amino-2-cyclopentyl-5-hydroxymethyl-pyrimidine in 12 ml of redistilled 2-picoline is mixed with stirring with 2.15 g of p-toluenesulfonyl chloride. The reaction mixture is allowed to stand for 36 hours at room temperature and is then diluted with ether, a gum-like precipitate forming which crystallizes on tearing]. The excess 2-picoline is removed by decanting off the excess liquid, the precipitate is dissolved in isopropanol and precipitated with ether. The precipitation is repeated a further 3 times. The solid material is finally dissolved in 100 ml of 0.06-n hydrochloric acid and the solution is poured through an ion exchange resin in chloride form (Amberlite ÆRA 400). The eluate is evaporated on a steam bath and thus 4-amino-2-cyclopentyl-5-(2-methyl-pyridinium)-methylpyrimidine chloride-hydrochloride is obtained! , with formula ; ; Example 5. 1,;j;A solution of 18.5 g of 4-amino-2-cyclopropyl-methyl-5-hydroxy-methyl-pyrimidine in 100 ml of 2-picoline is mixed with 19.9 g of p-toluenesulfonyl chloride. The reaction mixture is allowed to stand for 4 days at room temperature and is then diluted with ether, a precipitate forming. The above solution is decanted off, the residue is dissolved in isopropanol and the product is precipitated with ether, the precipitation is repeated 4 times, until no more 2-picoline can be determined. The solid material is dissolved in 100 ml of water and the solution is poured through a column containing an ion exchanger (Amberlite IRA ;400) in chloride form. The aqueous filtrate is evaporated under reduced pressure and the mra sidfuar a 'soomlkredess ta4l-almisineroe-2s -fcrya kloepn rboplaynld-minetg yalv -5m-e(t2a-nmoetl oğl -pyrisoipdrinopiuamno-1;;methyl)-pyrimidine-chloride-hydrochloride with formula; ; which melts at 225.5 - 226.5°C. ;The starting material is prepared in the following way:;To a suspension of 4l.l g of lithium aluminum hydride in;;300 ml of anhydrous ether, a solution of 100 g of cyclopropanecarbonic acid in 300 ml of ether is added while stirring so that the solvent is boiled gently, stirred for 8 hours and boiled under reflux. The reaction mixture is then diluted with 500 ml of ether, and 130 ml of a 15% aqueous sodium hydroxide solution is stirred in under ice cooling, the mixture is filtered and the residue is washed with ether, the filtrate is dried and evaporated. The residue is distilled and cyclopropyl methanol is recovered at 122-126°c'. n^<5>s .1.4299. A solution of 89.1 g of cyclopropyl methanol is dissolved in 350 ml of anhydrous ether, the solution is cooled to -70°C and 40.8 g of phosphorus tribromide is added dropwise with stirring over the course of \ hour. During 16 hours, the temperature of the mixture is allowed to rise to room temperature and then mixed with 12 ml of water, and the organic layer is separated, washed with saturated aqueous sodium carbonate solution and water, dried and evaporated. The residue is distilled and the cyclopropylmethyl bromide is recovered at 102-110°C n^5 = 1.4752. A suspension of 51.9 g of sodium cyanide in 377 ml of dimethyl sulfoxide is mixed with 126.5 g of cyclopropyl methyl bromide, the temperature being kept between 55-60°C. The temperature is then raised to 70°C for two hours, the mixture is cooled, diluted with 500 ml of water and extracted with ether. The extract is washed with water<p>g 25 ml of n-hydrochloric acid, dried and evaporated and the residue is distilled, the cyclopropyl acetonitrile is recovered at 142-147°C, n^<5>= 1.4218. Into a solution of 101 g of cyclopropylacetonitrile in 61.4 g of anhydrous ethanol, chlorine hydrogen gas is introduced until 48.3 g of this has been taken up. After the mixture has stood overnight, the formed precipitate is filtered off at -20°C, washed with water and dried under reduced pressure. The hygroscopic cyclopropyl acetimino ethyl ether hydrochloride is thus obtained. ;To the solution of 173.1 g of cyclopropyl-acetiminoethyl-ether hydrochloride in 100 ml of anhydrous ethanol, 130 ml of 6.3_n ethanolic ammonia is quickly added while stirring and cooling. The reaction mixture is allowed to stand for 16 hours at room temperature, the filtrate is filtered and concentrated to half the volume, after which, after ice-cooling and rubbing, crystallization is formed. The cyclopropyl-acetamidine hydrochloride formed is filtered off, washed with anhydrous ether and dried under reduced pressure. The solution of 136.6 g of cyclopropyl acetamidine hydrochloride in 700 ml of anhydrous ethanol is added to the solution formed by 23.6 g of sodium and 950 ml of anhydrous ethanol over the course of 1 hour with stirring at 15°C. After adding filter cellulose, the mixture is filtered through a glass internutsch and the filtrate is added to the solution of 130 g of ethoxymethylenemalodinitrile in 130 ml of anhydrous ethanol during 1/4 hour at -5 to -10°C. The mixture is stirred for 3 hours at this temperature, the residue is filtered and washed with cold anhydrous ethanol and dried in a vacuum at 50°C. One thus obtains 4-amino-5-cyano-2-cyclopropyl-methyl-pyrimidine, m.p. 181-182.5°C. The suspension of 17.4 g of 4-amino-5-cyano-2-cyclopropyl-methyl-pyrimidine and 2.5 g of a 10% palladium-on-charcoal catalyst in 200 ml of glacial acetic acid is saturated with anhydrous hydrogen chloride and is hydrated at an initial pressure of 10.2 atmospheres, after approx. 6 hours, the theoretical amount of hydrogen has been absorbed. The mixture is diluted with water, filtered and the filtrate is evaporated under reduced pressure. Isopropanol is added to the residue, which is distilled again to remove water and acetic acid. Finally, the residue is heated on a steam bath for one hour under reduced pressure and recrystallized from a mixture of isopropanol and methanol, thus obtaining 4-amino-5-aminomethyl-2-cyclopropylmethyl-pyrimidine dihydrochloride with m.p. 228.5-229°C. ;To a solution of 75>8 g of 4-amino-5-aminomethyl-2-cyclo-propylmethyl-pyrimidine dihydrochloride in 1000 ml of water, at 55°C, during 2 1/4 hours with stirring, the solution of 23 g sodium nitrite in 100 ml of water, the mixture is then kept for 6 hours at 54°C and 16 hours at room temperature. It is then treated with charcoal after adding filtration cellulose, filtered and the filtrate is concentrated under reduced pressure to a volume of 500 ml. The concentrate is cooled to 5°, neutralized with saturated sodium carbonate solution to pH 7.5 - 8.0 and extracted with n-butanol, the extract is dried and concentrated under reduced pressure until crystallization begins. After adding ether, the mixture is filtered, the residue is washed with ether, thus obtaining 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine, m.p. 143-146°C. ;The transfer of 4-amino-5-aminomethyl-2-cyclopropyl-methyl-pyrimidine dihydrochloride in 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine can also be carried out in the following way: To a solution of 26.6 g 4 -amino-5-aminomethyl-2-cyclopropylmethyl-pyrimidine dihydrochloride in 400 ml of water, the solution of 7.5 g of sodium nitrite in 400 ml of water is placed over the course of 3 hours, the temperature being kept at 50-55°C. The homogeneous solution is stirred for 17 hours at this temperature, during which time the pH is gradually adjusted to approx. 7.5-8 with saturated sodium carbonate solution. The mixture is evaporated to dryness and the yellow residue is extracted with 4 portions of boiling 90% aqueous acetone. The organic solution is evaporated to a small volume and the remaining water is removed azeotropically with ethanol. The mixture is filtered, the filtrate is acidified with ethanolic hydrochloric acid to a pH of approx. 4 and dilute with ether. After a short period of time, the precipitated yellow precipitate is filtered off, ground in a mortar with ether, filtered off and dried in a vacuum at 50°C. The formed 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine hydrochloride is dissolved in the minimal amount of water required for dissolution and solid potassium carbonate is added to the solution while cooling and stirring until an oily layer separates. It is then extracted with n-butanol until the latter extract is colourless. The combined extracts are dried over potassium carbonate, filtered and evaporated under reduced pressure. The residue is expelled with ether, filtered off, washed with ether and dried in vacuum at 50°C. 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine is thus obtained. ;Example 6. ;A solution of 2.2 g of 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine in 15 ml of freshly distilled 2,4-lutidine is mixed with 2.24 g of p-toluenesulfonyl chloride and the mixture is allowed to stand for 4 days at room temperature. It is then diluted with ether, whereupon a precipitate forms, from which the above solution is decanted. The residue is dissolved in isopropanol and the product is precipitated 4 times with ether, after which the smell of 2,4-lutidine disappears. The formed crystalline product is dissolved in 100 ml of water and the solution is passed through a column with an ion exchange resin present in chloride form (Amberlite IRA 400). The aqueous eluate is concentrated under reduced pressure and the precipitate formed is recrystallized from a mixture of methanol and isopropyl alcohol. ^1. One thus obtains 4-amino-2-cyclopropylmethyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidine-chloride-hydrochloride with ; which melts at 250.5 - 251°C during decomposition. ;Example 7 . A solution of 19 g of 4-amino-2-cyclopropyl-methyl-5-hydroxymethyl-pyrimidine in 100 ml of 2,4-lutidine is cooled and mixed in portions with 20.4 g of p-toluenesulfonyl chloride. The mixture is filtered and the filtrate is left for 18 hours at -20°C and 5 days at room temperature and; then diluted with ether. The gum-like precipitate is expelled; with ether and recrystallized from a mixture of isopropanol. and ether. A solution of 40.3 g of the crystalline material in 3.00 ml of water, containing 5 ml of 0.006 N hydrochloric acid, is treated with activated carbon, filtered and the filtrate is passed through a column with an ion exchange resin in chloride form (Amberlite IRA 400). The column is washed with 500 ml of water, the combined eluates are treated again with activated carbon, filtered and evaporated under reduced pressure. Isopropanol is added to the residue, which is distilled off to azeotropically remove remaining water. The thus dried residue is suspended in acetone and the suspension is filtered. The residue is washed with acetone and recrystallized from a 1:1 mixture of methanol and isopropanol. One thus obtains 4-amino-2-cyclopropyl-methyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidin-chloride hydrochloride, m.p. 250.5 - 251 oC during cleavage, which is identical to the product formed according to example 6. Example 8. A suspension of 2.7 g of 4-amino-5-chloromethyl-2-cyclopropylmethyl-pyrimidine hydrochloride in 20 ml of 2,4-lutidine is heated for 4 days on a steam bath, then cooled and diluted with ether. The supernatant solution is decanted off and the residue is boiled with isopropanol. After cooling, it is filtered and the residue is washed with isopropanol and recrystallized from a mixture of methanol and isopropanol. The formed 4-amino-2-cyclopropyl-methyl-5-(2,4-dimethyl-pyridinium)-methyl-pyrimidine-chloride-hydrochloride melts at 252°C during cleavage and is identical to that in the method according to example 6 and 7 formed product. ;The starting material can be obtained in the following way:;A solution of 5.8 g of 4-amino-2-cyclopropylmethyl-5-hydroxymethyl-pyrimidine in 10 ml of dimethylformamide is mixed with stirring and cooling to a temperature below 5°C dropwise with 2.45 ml of thionyl chloride. After stirring for two hours while cooling in an ice bath, the reaction mixture is allowed to stand for 18 hours at 0°C, then diluted with ether and the precipitate filtered off. This is triturated with ether and acetone and recrystallized from a mixture of isopropanol and ether, 4-amino-5-chloromethyl-2-cyclopropylmethyl-pyrimidine hydrochloride melts at 191-195°C with decomposition.*

Claims (1)

1. Fremgangsmåte til fremstilling av terapeutisk virksomme forbindelser med formel1. Process for the preparation of therapeutically active compounds with formula hvori n betyr et helt tall fra 2 til 5, m betyr et helt tall fra 1 til 4 og p betyr et helt tall fra 0 til 2, Y betyr en direkte binding eller en metylen, 1,1-etylen- eller 1,2-etylengruppe og X <®> betyr et syreanion samt syreaddisjonssalter herav, karakterisert ved at man entena) omsetter en reaksjonsdyktig ester eller eter av en forbindelse med formel wherein n means an integer from 2 to 5, m means an integer from 1 to 4 and p means an integer from 0 to 2, Y means a direct bond or a methylene, 1,1-ethylene or 1,2 -ethylene group and X <®> means an acid anion and acid addition salts thereof, characterized by either) reacting a reactive ester or ether of a compound of formula hvori RQ betyr en hydroksy- eller merkaptogruppe, eller et salt herav med en forbindelse med formel wherein RQ means a hydroxy or mercapto group, or a salt of which with a compound of formula eller b) omdanner en til forbindelsen med formel I svarende kvaternære base eller pseudobase i det kvaternære salt og hvis ønsket, overfører en dannet fri forbindelse i dens syreaddisjonssalt eller et dannet syreaddisjonssalt i den frie forbindelse eller i et annet salt og/eller omdanner et resulterende kvaternært salt i et annet kvaternært salt. 2..Fremgangsmåte ifølge krav 1, karakterisert ved at man omsetter en reaksjonsdyktig ester eller eter av en 4-amino-2-cyklopropylmetyl-5-R0 -nietyl-pyrimidin, hvori RQ betyr en hydroksy- eller merkaptogruppe eller et salt herav med 2,4-lutidin eller et salt herav. 3. Fremgangsmåte ifølge krav 1, karakterisert ved at man omsetter en reaksjonsdyktig ester eller eter av et 4-amino-2-cyklopropylmetyl-5-R0-nietyl-pyrimidinj hvori R betyr en hydroksy- eller merkaptogruppe, eller et salt herav med 2-picolin eller et salt herav.or b) converts a quaternary base or pseudobase corresponding to the compound of formula I into the quaternary salt and, if desired, transfers a formed free compound into its acid addition salt or a formed acid addition salt into the free compound or into another salt and/or converts a resulting quaternary salt in another quaternary salt. 2.. Method according to claim 1, characterized in that one reacts a reactive ester or ether of a 4-amino-2-cyclopropylmethyl-5-R0 -niethylpyrimidine, in which RQ means a hydroxy or mercapto group or a salt thereof with 2 ,4-lutidine or a salt thereof. 3. Process according to claim 1, characterized in that one reacts a reactive ester or ether of a 4-amino-2-cyclopropylmethyl-5-R0-niethyl-pyrimidine in which R means a hydroxy or mercapto group, or a salt thereof with 2- picolin or a salt thereof.
NO164999A 1965-10-05 1966-10-04 NO122650B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49323365A 1965-10-05 1965-10-05
US53466666A 1966-03-16 1966-03-16
US57267166A 1966-08-16 1966-08-16
US592314A US3385857A (en) 1965-10-05 1966-11-07 Cycloaliphatic pyrimidines

Publications (1)

Publication Number Publication Date
NO122650B true NO122650B (en) 1971-07-26

Family

ID=27504357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO164999A NO122650B (en) 1965-10-05 1966-10-04

Country Status (14)

Country Link
US (1) US3385857A (en)
AT (2) AT277653B (en)
BE (2) BE687778A (en)
BR (2) BR6683425D0 (en)
CH (1) CH484168A (en)
DE (1) DE1670389A1 (en)
DK (1) DK122326B (en)
FI (1) FI45115C (en)
FR (1) FR1503663A (en)
GB (2) GB1116388A (en)
IL (1) IL26554A (en)
NL (2) NL6613986A (en)
NO (1) NO122650B (en)
SE (1) SE331786B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454575A (en) * 1967-03-06 1969-07-08 Ciba Geigy Corp Quaternary 5-ammonium-methyl-4-amino-2 cycloaliphatylpyrimidine salts
BE795071A (en) * 1972-02-08 1973-08-07 Merck & Co Inc COCCIDIOSTATIC COMPOUNDS
US4006143A (en) * 1974-04-09 1977-02-01 Merck & Co., Inc. Heterocyclic substituted pyrimidine compounds
US4044133A (en) * 1974-04-18 1977-08-23 Merck & Co., Inc. Anticoccidial compositions
US6077981A (en) * 1998-08-28 2000-06-20 Eastman Chemical Company Process for the production of cyclopropylmethyl halides
US6118032A (en) * 1999-08-03 2000-09-12 Eastman Chemical Company Process for the production of cyclopropylmethyl halides
EP1234508A1 (en) * 2001-02-21 2002-08-28 Universiteit Gent Antiprotozoal methods, compositions and feedstuffs
CN111760032B (en) * 2020-07-22 2022-02-25 广州白云山宝神动物保健品有限公司 Composition for preventing and treating drug-resistant coccidiosis of chicken and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042676A (en) * 1960-02-02 1962-07-03 Merck & Co Inc Pyridinium quaternary salts and methods of preparing the same

Also Published As

Publication number Publication date
DE1670389A1 (en) 1970-11-05
FI45115C (en) 1972-03-10
IL26554A (en) 1971-04-28
NL6613987A (en) 1967-04-06
SE331786B (en) 1971-01-11
AT281040B (en) 1970-05-11
CH484168A (en) 1970-01-15
FR1503663A (en) 1967-12-01
BE687779A (en) 1967-04-04
BE687778A (en) 1967-04-04
BR6683424D0 (en) 1973-12-04
DK122326B (en) 1972-02-21
NL6613986A (en) 1967-04-06
AT277653B (en) 1970-01-12
GB1116388A (en) 1968-06-06
US3385857A (en) 1968-05-28
FI45115B (en) 1971-11-30
GB1116389A (en) 1968-06-06
BR6683425D0 (en) 1973-12-04

Similar Documents

Publication Publication Date Title
US2966488A (en) Substituted alkylaminopurines
NO151876B (en) PROCEDURE AND APPARATUS FOR ANIMAL LINING
NO146541B (en) PROCEDURE FOR PREPARING SOFT ETHYLENIC POLYMER RESIN FOAM
CN114805314B (en) Synthesis method of Entecavir
NO122650B (en)
NO119949B (en)
NO782230L (en) PROCEDURES FOR THE PREPARATION OF N-AMIDINO-3,5-DIAMINO-6-SUBSTITUTED-2-PYRAZINE CARBOXAMIDE
McKay et al. Amino Acids. II. Synthesis of Cyclic Guanidino Acids1
US3449357A (en) 2-((2,6-substituted)phenoxymethyl)-2-imidazolines
NO784350L (en) PROCEDURE FOR ALKYLATION OF 4 (5) -MERCAPTOMETHYL-IMIDAZOLES WITH AZIRIDINE DERIVATIVES
Bergel et al. 19. Cyto-active amino-acids and peptides. Part V. Derivatives of p-amino-and p-mercapto-phenylalanine
DE2534962B2 (en) cis-3,4-ureylenethiophane-1,1-dioxide and process for its preparation
NO166636B (en) EXPLOSION INCLUDING A MIXTURE OF A NITRATE OIL EXPLOSION AND A WATER-IN-OIL EMULSION EXPLOSION AND PROCEDURE FOR ITS PREPARATION.
US2377395A (en) Pyrimidine derivatives and peocesb
US2727041A (en) Isonicotinyl hydrazone of m-formyl-benzene sulfonic acid
Birtwell et al. 334. Synthetic antimalarials. Part XXX. Some N 1-aryl-N 4: N 5-dialkyldiguanides and observations on the conversion of guanylthioureas into diguanides
US2676175A (en) Process for manufacturing thiamine
US2910505A (en) S-substituted n-benzhydryl pseudothioureas and their pseudothiouronium salts
CN115677654B (en) Preparation method of atecan hydrochloride
Light et al. CCCXVI.—Bromo-derivatives of 2-methylglyoxaline
Boon et al. The preparation of ornithine, ornithuric acid and α-benzoylornithine
NO133892B (en)
McCown et al. Alkaline Hydrolysis of Fluorenone-spirohydantoin1
US3590044A (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2-carboxamidines
US2220243A (en) 2-methyl-4-amino-5-thioformyl-aminomethylpyrimidine and process for the manufacture of amides of thioformic acid